Novozymes EPS - Earnings per Share 2011-2024 | NVZMY
Novozymes annual and quarterly earnings per share history from 2011 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Novozymes EPS for the quarter ending June 30, 2024 was $0.00, a 100% decline year-over-year.
- Novozymes EPS for the twelve months ending June 30, 2024 was $1.17, a 35.67% decline year-over-year.
- Novozymes 2024 annual EPS was $0.73, a 54.11% decline from 2023.
- Novozymes 2023 annual EPS was $1.58, a 15.42% decline from 2022.
- Novozymes 2022 annual EPS was $1.87, a 4.53% increase from 2021.
| Novozymes Annual EPS |
| 2024 |
$0.73 |
| 2023 |
$1.58 |
| 2022 |
$1.87 |
| 2021 |
$1.79 |
| 2020 |
$1.54 |
| 2019 |
$1.65 |
| 2018 |
$1.75 |
| 2017 |
$1.59 |
| 2016 |
$1.50 |
| 2015 |
$1.36 |
| 2014 |
$1.25 |
| 2013 |
$1.26 |
| 2012 |
$1.10 |
| 2011 |
$1.02 |
| 2010 |
$0.90 |
| Novozymes Quarterly EPS |
| 2024-06-30 |
$0.00 |
| 2023-12-31 |
$0.36 |
| 2023-09-30 |
$0.49 |
| 2023-06-30 |
$0.32 |
| 2023-03-31 |
$0.41 |
| 2022-12-31 |
$0.44 |
| 2022-09-30 |
$0.56 |
| 2022-06-30 |
$0.42 |
| 2022-03-31 |
$0.45 |
| 2021-12-31 |
$0.34 |
| 2021-09-30 |
$0.48 |
| 2021-06-30 |
$0.46 |
| 2021-03-31 |
$0.51 |
| 2020-12-31 |
$0.38 |
| 2020-09-30 |
$0.40 |
| 2020-06-30 |
$0.34 |
| 2020-03-31 |
$0.43 |
| 2019-12-31 |
$0.48 |
| 2019-09-30 |
$0.33 |
| 2019-06-30 |
$0.47 |
| 2019-03-31 |
$0.37 |
| 2018-12-31 |
$0.44 |
| 2018-09-30 |
$0.43 |
| 2018-06-30 |
$0.42 |
| 2018-03-31 |
$0.45 |
| 2017-12-31 |
$0.42 |
| 2017-09-30 |
$0.44 |
| 2017-06-30 |
$0.37 |
| 2017-03-31 |
$0.37 |
| 2016-12-31 |
$0.39 |
| 2016-09-30 |
$0.37 |
| 2016-06-30 |
$0.37 |
| 2016-03-31 |
$0.36 |
| 2015-12-31 |
$0.33 |
| 2015-09-30 |
$0.36 |
| 2015-06-30 |
$0.33 |
| 2015-03-31 |
$0.33 |
| 2014-12-31 |
$0.30 |
| 2014-09-30 |
$0.34 |
| 2014-06-30 |
$0.34 |
| 2014-03-31 |
$0.40 |
| 2013-12-31 |
$0.31 |
| 2013-09-30 |
$0.33 |
| 2013-06-30 |
$0.31 |
| 2013-03-31 |
$0.28 |
| 2012-12-31 |
$0.27 |
| 2012-09-30 |
$0.28 |
| 2012-06-30 |
$0.25 |
| 2012-03-31 |
$0.28 |
| 2011-12-31 |
$0.20 |
| 2011-09-30 |
$0.31 |
| 2011-06-30 |
$0.27 |
| 2011-03-31 |
$0.28 |
| 2010-12-31 |
$0.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$32.992B |
$4.149B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
